Medical devices, healthcare technology and the business of care
510(k) clearance · K262573

SPOTFIRE VG Control Panel M534, SPOTFIRE VG Negative Control

Maine Molecular Quality Controls, Inc. · Decision date Oct 21, 2026

MEDTECHLEDGER EXPLANATIONK262573

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-21 for K262573, a traditional 510(k) submitted 07/27/2026 by Maine Molecular Quality Controls, Inc. of Saco, Maine. The device is listed as SPOTFIRE VG Control Panel M534 and SPOTFIRE VG Negative Control, under the classification name Assayed External Control Material For Microbiology Nucleic Acid Amplification (NAT) Assays, regulation 866.3920, product code PMN, in the Microbiology specialty and review panel.

SESE means the submission was cleared to market; it is not a PMA approval. The record shows no third-party review, no combination product status and no authorized predetermined change control plan. The public record does not include the substantial-equivalence basis, the predicate device, the control panel's target analytes, or performance data, so the specific components and any changed items cannot be described from this source.

The page was last updated 11/02/2026. No clinical or analytical performance conclusions are drawn here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Microbiology
Decision date
Oct 21, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262573
Regulatory pathway
510(k) premarket notification
Product code
PMN
Decision code
SESE
Decision date
Oct 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays.

Product code
PMN
FDA device class
2

FDA decision timeline

  1. K262573 received

    Application receipt date recorded by FDA.

  2. K262573 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code PMN

Product / regulatory recordCompanyPathwayDecision dateSource
BioFire Defense, LLC510(k) clearanceNov 4, 2026FDA
Maine Molecular Quality Controls, Inc.510(k) clearanceOct 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Maine Molecular Quality Controls, Inc.

Headquarters
Not reported
Brand website
mmqci.com
FDA applicant address
Saco, ME

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records